NasdaqCM - Nasdaq Real Time Price USD

Amarin Corporation plc (AMRN)

11.11

+0.12

+(1.09%)

At close: May 23 at 4:00:00 PM EDT

11.03

-0.08

(-0.72%)

After hours: May 23 at 6:37:28 PM EDT

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Name	Title	Pay	Exercised	Year Born
Mr. Aaron D. Berg	CEO, President & Director	1.25M	--	1963
Mr. Peter L. Fishman	Chief Financial Officer	472.9k	--	1984
Dr. Steven B. Ketchum Ph.D.	Executive VP, President of Research & Development and Chief Scientific Officer	1.17M	--	1965
Mr. Jonathan N. Provoost	Executive VP, Chief Legal & Compliance Officer and Secretary	701.82k	--	1970
Mr. Jordan Zwick	Senior VP of Corporate Business Development & Investor Relations	--	--	1987
Mr. Laurent Abuaf	President of Europe & Senior VP	--	--	--
Dr. Nabil Abadir	Chief Medical Officer of Global Medical Affairs	--	--	--
Dr. David Keenan Ph.D.	Executive VP of Technical Operations & President of Europe	--	--	--

One Central Plaza

5th Floor 36 Dame Street

Dublin 2, D02 K7K5

Ireland

353 0 166 99020 https://www.amarincorp.com

Sector:: Healthcare
Industry:
Full Time Employees:: 275

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.

Amarin Corporation plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

July 29, 2025 at 12:30 PM UTC - August 4, 2025 at 12:30 PM UTC

Amarin Corporation plc Earnings Date

May 15, 2025 at 12:00 AM UTC